Jul 10, 2012, 08:00 ET "This marks our second acquisition in the past year for Carex," said J. Randall Keene, Partner with Ancor and Director of Carex. "Ancor teamed up with Merit Capital approximately two years ago to acquire Carex Health Brands, and our…
Merck and Moderna’s new personalized cancer vaccine paired with the standard of care reduced the risk of recurrence and death for patients with melanoma by 42 percent. Merck and Moderna’s recent Phase 3 trial data of their personalized mRNA vaccine for melanoma…
GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing... Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to…
Gaurav Aggarwal, a Managing Partner at Vivo Capital, said: “We are now realizing the vision we laid out years ago with Dan of adding commercial capabilities to create a true end-to-end offering. I know I speak for my Vivo colleagues…
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell…
A new mouse study reports that the adipokine asprosin promotes obesity by inducing ferroptosis in brown adipocytes through inhibition of Notch3/RBP-Jκ/VDAC3 signaling. Within those limits, the study adds asprosin to a growing list of adipose-derived signals implicated in obesity pathogenesis,…
Since September of last year, a team of Danish researchers, backed by $1.6 million in funding from RFK Jr.’s CDC, had planned a large-scale hepatitis B vaccine trial in the sub-Saharan African nation of Guinea-Bissau. · Screening mothers for hepatitis B…
Alexandria Real Estate Equities is shedding portions of some of its marquee life sciences campuses as the REIT grapples with shifting priorities in a biotech market that remains oversupplied and slow to recover from the pandemic-era building boom. During the…
San Diego biotech Artiva Biotherapeutics is laying off about 94% of its workforce and abandoning its lead immunotherapy treatment for rheumatoid arthritis roughly five months after raising about $300 million from investors. The company said Tuesday that updated data showed its lead…
When asked whether they should have run tests in more animals, co-author Hui Yang, co-founder of HuidaGene, said that increasing animal numbers alone could not guarantee prediction of an uncommon reaction in people, particularly because different species have different immune…
Biotech and Pharma: hiring, expansion, leadership and results.
An article joins this feed when it matches these terms. Each one is also a search of its own.